DETAILING AGREEMENT between sanofi-aventis US LLC and Relypsa, Inc. Dated as of August 10, 2015Detailing Agreement • November 4th, 2015 • Relypsa Inc • Pharmaceutical preparations • New York
This detailing agreement (the “Agreement”) is effective as of August 10, 2015 (the “Effective Date”) by and between Relypsa, Inc., a Delaware corporation located at 100 Cardinal Way, Redwood City, CA 94063, USA (“Relypsa”) and sanofi-aventis US LLC, a Delaware limited liability company located at 55 Corporate Drive, Bridgewater NJ 08807 (“Sanofi”). Relypsa and Sanofi are referred to individually as a “Party” and collectively as the “Parties”.
FOURTH AMENDMENT TO LOAN AND SECURITY AGREEMENTLoan and Security Agreement • November 4th, 2015 • Relypsa Inc • Pharmaceutical preparations • California
LICENSE AGREEMENTLicense Agreement • November 4th, 2015 • Relypsa Inc • Pharmaceutical preparations • New York
This License Agreement (the “Agreement”) is effective as of August 10, 2015 (the “Effective Date”) between Relypsa, Inc., a Delaware corporation located at 100 Cardinal Way, Redwood City, CA 94063, USA (“Relypsa”), and Vifor Fresenius Medical Care Renal Pharma Ltd., a corporation that is established in accordance with Swiss laws and registered in the commercial registry under CH-320.3.033.350-1 and that is located at Rechenstrasse 37, CH-9014 St. Gallen, Switzerland (“VFMCRP”). Relypsa and VFMCRP are referred to individually as a “Party” and collectively as the “Parties.”
